Stock Evaluator: Canton Strategic Holdings, Inc. (CNTN)

Canton Strategic Holdings, Inc. CNTN

$2.28 0.03 1.33%
September 4, 2026 4:00:00 PM EST November 10, 2021 Volume: 409,047
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

Commentary & Analysis


Financial Summary

Share Statistics CNTN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $181.7 $282.4 26%
Shares Out (Mil) 77.3 54.0 57%
Institutional Ownership 78.1% 93.1% 47%
Float (Mil) 72.7 42.2 55%
Beta 1.47 0.94 82%
Avg Daily Volume (000s) 625 482 64%
Price Change
(52-week)
(42.9%) 59.9% 18%
Growth CNTN Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 14.1% na
Net Income (5yr) (71.8%) (10.1%) 4%
EPS (5yr) 62.1% 15.9% 96
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) (45.9%) (15.6%) 9%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials CNTN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $37 3%
Net Income (TTM) (Mil) ($98) ($43) 11%
EPS (TTM) ($1.270) ($1.500) 19%
Operating Cash Flow (TTM) (Mil) ($22) ($31) 14%
Net Cash Flow (TTM) (Mil) na $2 na
Long-Term Debt (Q1) (Mil) $0 $4 0%
Enterprise Value (Q1) (Mil) $137 $190 23%
Valuation CNTN Industry
Median
Percentile
(All Stocks)
P/B 0.39 2.84 6%
P/E na 20.2 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.0 na
Ratios CNTN Industry
Median
Percentile
(All Stocks)
Gross Margin 100.0% 66.9% 96%
Net Margin na (74.2%) na
ROA (34.6%) (47.7%) 15%
ROE (43.1%) (55.0%) 17%
Liabilities to Assets 19.4% 29.8% 13%
F-Score 3 3 18%

Canton Strategic Holdings, Inc. did not pass any screens on 9/4/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors